Clinical Trial Update: Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating L-carnitine versus placebo for fatigue in multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED